Anthony A. Campagnari - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Microbiology

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bair KL, Shafirstein G, Campagnari AA. Photodynamic Therapy of Polymicrobial Biofilms Commonly Associated With Otitis Media. Frontiers in Microbiology. 11: 558482. PMID 32983076 DOI: 10.3389/Fmicb.2020.558482  0.346
2019 Bair KL, Campagnari AA. Promotes Stable Polymicrobial Biofilms With the Major Otopathogens. Frontiers in Microbiology. 10: 3006. PMID 32010085 DOI: 10.3389/Fmicb.2019.03006  0.394
2018 Reddinger RM, Luke-Marshall NR, Sauberan SL, Hakansson AP, Campagnari AA. Streptococcus pneumoniae Modulates Staphylococcus aureus Biofilm Dispersion and the Transition from Colonization to Invasive Disease. Mbio. 9. PMID 29317512 DOI: 10.1128/Mbio.02089-17  0.362
2017 Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children. Vaccine. PMID 28755833 DOI: 10.1016/J.Vaccine.2017.07.027  0.303
2016 Canty M, Luke-Marshall N, Campagnari A, Ehrensberger M. Cathodic voltage-controlled electrical stimulation of titanium for prevention of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii biofilm infections. Acta Biomaterialia. 48: 451-460. PMID 27890730 DOI: 10.1016/J.Actbio.2016.11.056  0.32
2016 Reddinger RM, Luke-Marshall NR, Hakansson AP, Campagnari AA. Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease. Mbio. 7. PMID 27507829 DOI: 10.1128/Mbio.01235-16  0.353
2015 Ren D, Almudevar AL, Murphy TF, Lafontaine ER, Campagnari AA, Luke-Marshall N, Casey JR, Pichichero ME. Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine. 33: 5809-14. PMID 26392013 DOI: 10.1016/J.Vaccine.2015.09.023  0.337
2014 Luke-Marshall NR, Mang TS, Hansen LA, Campagnari AA. Moraxella catarrhalis is susceptible to antimicrobial photodynamic therapy with Photofrin. Lasers in Surgery and Medicine. 46: 712-7. PMID 25154610 DOI: 10.1002/Lsm.22287  0.373
2013 Luke-Marshall NR, Edwards KJ, Sauberan S, St Michael F, Vinogradov EV, Cox AD, Campagnari AA. Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly. Glycobiology. 23: 1013-21. PMID 23720461 DOI: 10.1093/Glycob/Cwt042  0.562
2013 Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infection and Immunity. 81: 915-22. PMID 23297385 DOI: 10.1128/Iai.01184-12  0.34
2012 Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infection and Immunity. 80: 228-33. PMID 22083703 DOI: 10.1128/Iai.05913-11  0.76
2011 Davie JJ, Earl J, de Vries SP, Ahmed A, Hu FZ, Bootsma HJ, Stol K, Hermans PW, Wadowsky RM, Ehrlich GD, Hays JP, Campagnari AA. Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates. Bmc Genomics. 12: 70. PMID 21269504 DOI: 10.1186/1471-2164-12-70  0.757
2011 Luke-Marshall NR, Sauberan SL, Campagnari AA. Comparative analyses of the Moraxella catarrhalis type-IV pilus structural subunit PilA. Gene. 477: 19-23. PMID 21256201 DOI: 10.1016/J.Gene.2011.01.010  0.511
2010 Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infection and Immunity. 78: 3993-4000. PMID 20643860 DOI: 10.1128/Iai.00366-10  0.799
2010 Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW, Cox AD, St Michael F, Vinogradov EV, Campagnari AA. Identification and characterization of a glycosyltransferase involved in Acinetobacter baumannii lipopolysaccharide core biosynthesis. Infection and Immunity. 78: 2017-23. PMID 20194587 DOI: 10.1128/Iai.00016-10  0.785
2009 Schwingel JM, Edwards KJ, Cox AD, Masoud H, Richards JC, St Michael F, Tekwe CD, Sethi S, Murphy TF, Campagnari AA. Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies. Infection and Immunity. 77: 4548-58. PMID 19651870 DOI: 10.1128/Iai.00294-09  0.779
2009 Davie JJ, Campagnari AA. Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB. Journal of Bacteriology. 191: 2144-52. PMID 19103932 DOI: 10.1128/Jb.01487-08  0.776
2008 Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. Journal of Bacteriology. 190: 8053-64. PMID 18931120 DOI: 10.1128/Jb.00834-08  0.303
2008 Russo TA, Beanan JM, Olson R, MacDonald U, Luke NR, Gill SR, Campagnari AA. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infection and Immunity. 76: 3577-86. PMID 18541654 DOI: 10.1128/Iai.00269-08  0.766
2008 Schwingel JM, St Michael F, Cox AD, Masoud H, Richards JC, Campagnari AA. A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology. 18: 447-55. PMID 18337458 DOI: 10.1093/Glycob/Cwn021  0.796
2008 Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. Journal of Bacteriology. 190: 1036-44. PMID 18024522 DOI: 10.1128/Jb.01416-07  0.794
2007 Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infection and Immunity. 75: 5559-64. PMID 17908808 DOI: 10.1128/Iai.00946-07  0.804
2007 Plamondon P, Luke NR, Campagnari AA. Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infection and Immunity. 75: 2929-36. PMID 17420235 DOI: 10.1128/Iai.00396-07  0.806
2006 Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers. Microbial Pathogenesis. 40: 110-5. PMID 16426809 DOI: 10.1016/J.Micpath.2005.11.005  0.772
2005 Edwards KJ, Schwingel JM, Datta AK, Campagnari AA. Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates. Journal of Clinical Microbiology. 43: 6139-43. PMID 16333114 DOI: 10.1128/Jcm.43.12.6139-6143.2005  0.766
2005 Edwards KJ, Allen S, Gibson BW, Campagnari AA. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. Journal of Bacteriology. 187: 2939-47. PMID 15838019 DOI: 10.1128/Jb.187.9.2939-2947.2005  0.634
2005 Furano K, Luke NR, Howlett AJ, Campagnari AA. Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology (Reading, England). 151: 1151-8. PMID 15817782 DOI: 10.1099/Mic.0.27820-0  0.775
2004 Furano K, Campagnari AA. Identification of a hemin utilization protein of Moraxella catarrhalis (HumA). Infection and Immunity. 72: 6426-32. PMID 15501773 DOI: 10.1128/Iai.72.11.6426-6432.2004  0.811
2004 Prather DT, Bains M, Hancock RE, Filiatrault MJ, Campagnari AA. Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi. Infection and Immunity. 72: 6271-8. PMID 15501753 DOI: 10.1128/Iai.72.11.6271-6278.2004  0.742
2004 Luke NR, Howlett AJ, Shao J, Campagnari AA. Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infection and Immunity. 72: 6262-70. PMID 15501752 DOI: 10.1128/Iai.72.11.6262-6270.2004  0.817
2003 Luke NR, Allen S, Gibson BW, Campagnari AA. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infection and Immunity. 71: 6426-34. PMID 14573664 DOI: 10.1128/Iai.71.11.6426-6434.2003  0.802
2003 Furano K, Campagnari AA. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infection and Immunity. 71: 1843-8. PMID 12654799 DOI: 10.1128/Iai.71.4.1843-1848.2003  0.809
2002 Schilling B, Gibson BW, Filiatrault M, Campagnari AA. Characterization of lipooligosaccharides from Haemophilus ducreyi containing polylactosamine repeats. Journal of the American Society For Mass Spectrometry. 13: 724-34. PMID 12056572 DOI: 10.1016/S1044-0305(02)00375-6  0.709
2002 Tullius MV, Phillips NJ, Scheffler NK, Samuels NM, Munson Jr RS, Hansen EJ, Stevens-Riley M, Campagnari AA, Gibson BW. The lbgAB gene cluster of Haemophilus ducreyi encodes a beta-1,4-galactosyltransferase and an alpha-1,6-DD-heptosyltransferase involved in lipooligosaccharide biosynthesis. Infection and Immunity. 70: 2853-61. PMID 12010972 DOI: 10.1128/Iai.70.6.2853-2861.2002  0.438
2002 Luke NR, Karalus RJ, Campagnari AA. Inactivation of the Moraxella catarrhalis superoxide dismutase SodA induces constitutive expression of iron-repressible outer membrane proteins. Infection and Immunity. 70: 1889-95. PMID 11895952 DOI: 10.1128/Iai.70.4.1889-1895.2002  0.82
2001 Filiatrault MJ, Munson RS, Campagnari AA. Genetic analysis of a pyocin-resistant lipooligosaccharide (LOS) mutant of Haemophilus ducreyi: restoration of full-length LOS restores pyocin sensitivity. Journal of Bacteriology. 183: 5756-61. PMID 11544241 DOI: 10.1128/Jb.183.19.5756-5761.2001  0.71
2001 Young RS, Filiatrault MJ, Fortney KR, Hood AF, Katz BP, Munson RS, Campagnari AA, Spinola SM. Haemophilus ducreyi lipooligosaccharide mutant defective in expression of beta-1,4-glucosyltransferase is virulent in humans. Infection and Immunity. 69: 4180-4. PMID 11349097 DOI: 10.1128/Iai.69.6.4180-4184.2001  0.718
2000 Zaleski A, Scheffler NK, Densen P, Lee FKN, Campagnari AA, Gibson BW, Apicella MA. Lipooligosaccharide P(k) (Galα1-4Galβ1-4Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum Infection and Immunity. 68: 5261-5268. PMID 10948153 DOI: 10.1128/Iai.68.9.5261-5268.2000  0.447
2000 Karalus R, Campagnari A. Moraxella catarrhalis: A review of an important human mucosal pathogen Microbes and Infection. 2: 547-559. PMID 10865200 DOI: 10.1016/S1286-4579(00)00314-2  0.331
2000 Filiatrault MJ, Gibson BW, Schilling B, Sun S, Munson RS, Campagnari AA. Construction and characterization of Haemophilus ducreyi lipooligosaccharide (LOS) mutants defective in expression of heptosyltransferase III and beta1,4-glucosyltransferase: identification of LOS glycoforms containing lactosamine repeats. Infection and Immunity. 68: 3352-61. PMID 10816485 DOI: 10.1128/Iai.68.6.3352-3361.2000  0.739
1999 Young RS, Fortney K, Haley JC, Hood AF, Campagnari AA, Wang J, Bozue JA, Munson RS, Spinola SM. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers. Infection and Immunity. 67: 6335-40. PMID 10569746 DOI: 10.1128/Iai.67.12.6335-6340.1999  0.396
1999 Luke NR, Campagnari AA. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infection and Immunity. 67: 5815-9. PMID 10531234 DOI: 10.1128/Iai.67.11.5815-5819.1999  0.797
1999 Luke NR, Russo TA, Luther N, Campagnari AA. Use of an isogenic mutant constructed in Moraxella catarrhalis To identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6. Infection and Immunity. 67: 681-7. PMID 9916077 DOI: 10.1128/Iai.67.2.681-687.1999  0.801
1997 Inzana TJ, Hensley J, McQuiston J, Lesse AJ, Campagnari AA, Boyle SM, Apicella MA. Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus. Infection and Immunity. 65: 4675-81. PMID 9353049 DOI: 10.1128/Iai.65.11.4675-4681.1997  0.368
1997 Gibson BW, Campagnari AA, Melaugh W, Phillips NJ, Apicella MA, Grass S, Wang J, Palmer KL, Munson RS. Characterization of a transposon Tn916-generated mutant of Haemophilus ducreyi 35000 defective in lipooligosaccharide biosynthesis Journal of Bacteriology. 179: 5062-5071. PMID 9260947 DOI: 10.1128/Jb.179.16.5062-5071.1997  0.415
1996 Hiltke TJ, Campagnari AA, Spinola SM. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi Infection and Immunity. 64: 5047-5052. PMID 8945545 DOI: 10.1128/Iai.64.12.5047-5052.1996  0.374
1996 Campagnari AA, Ducey TF, Rebmann CA. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin Infection and Immunity. 64: 3920-3924. PMID 8751951 DOI: 10.1128/Iai.64.9.3920-3924.1996  0.461
1996 Spinola SM, Orazi A, Arno JN, Fortney K, Kotylo P, Chen CY, Campagnari AA, Hood AF. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection Journal of Infectious Diseases. 173: 394-402. PMID 8568301 DOI: 10.1093/Infdis/173.2.394  0.319
1996 Melaugh W, Campagnari AA, Gibson BW. The lipooligosaccharides of Haemophilus ducreyi are highly sialylated Journal of Bacteriology. 178: 564-570. PMID 8550483 DOI: 10.1128/Jb.178.2.564-570.1996  0.33
1995 Russo TA, Sharma G, Brown CR, Campagnari AA. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo Infection and Immunity. 63: 1263-1269. PMID 7890383 DOI: 10.1128/Iai.63.4.1263-1269.1995  0.339
1994 Campagnari AA, Karalus R, Apicella M, Melaugh W, Lesse AJ, Gibson BW. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis Infection and Immunity. 62: 2379-2386. PMID 8188362 DOI: 10.1128/Iai.62.6.2379-2386.1994  0.367
1994 Spinola SM, Wild LM, Apicella MA, Gaspari AA, Campagnari AA. Experimental human infection with haemophilus ducreyi Journal of Infectious Diseases. 169: 1146-1150. PMID 8169411 DOI: 10.1093/Infdis/169.5.1146  0.329
1994 Brentjens RJ, Spinola SM, Campagnari AA. Haemophilus ducreyi adheres to human keratinocytes Microbial Pathogenesis. 16: 243-247. PMID 8090082 DOI: 10.1006/Mpat.1994.1025  0.402
1994 Melaugh W, Phillips NJ, Campagnari AA, Tullius MV, Gibson BW. Structure of the major oligosaccharide from the lipooligosaccharide of Haemophilus ducreyi strain 35000 and evidence for additional glycoforms Biochemistry. 33: 13070-13078. PMID 7947712 DOI: 10.1021/Bi00248A016  0.371
1994 Campagnari AA, Shanks KL, Dyer DW. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: Expression of iron-repressible proteins without siderophore production Infection and Immunity. 62: 4909-4914. PMID 7927771 DOI: 10.1128/Iai.62.11.4909-4914.1994  0.44
1993 Gibson BW, Melaugh W, Phillips NJ, Apicella MA, Campagnari AA, Griffiss JM. Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry Journal of Bacteriology. 175: 2702-2712. PMID 8386724 DOI: 10.1128/Jb.175.9.2702-2712.1993  0.322
1992 Sarwar J, Campagnari AA, Kirkham C, Murphy TF. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis Infection and Immunity. 60: 804-809. PMID 1371769 DOI: 10.1128/Iai.60.3.804-809.1992  0.382
1991 Haase EM, Campagnari AA, Sarwar J, Shero M, Wirth M, Cumming CU, Murphy TF. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae Infection and Immunity. 59: 1278-1284. PMID 1706317 DOI: 10.1128/Iai.59.4.1278-1284.1991  0.422
1990 Campagnari AA, Spinola SM, Lesse AJ, Kwaik YA, Mandrell RE, Apicella MA. Lipooligosaccharide epitopes shared among Gram-negative non-enteric mucosal pathogens Microbial Pathogenesis. 8: 353-362. PMID 1699109 DOI: 10.1016/0882-4010(90)90094-7  0.375
1990 Spinola SM, Kwaik YA, Lesse AJ, Campagnari AA, Apicella MA. Cloning and expression in Escherichia coli of a Haemophilus influenzae type b lipooligosaccharide synthesis gene(s) that encodes a 2-keto-3-deoxyoctulosonic acid epitope Infection and Immunity. 58: 1558-1564. PMID 1692806 DOI: 10.1128/Iai.58.6.1558-1564.1990  0.361
1988 Westerink MAJ, Campagnari AA, Wirth MA, Apicella MA. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C Infection and Immunity. 56: 1120-1127. PMID 3128477 DOI: 10.1128/Iai.56.5.1120-1127.1988  0.309
1987 Campagnari AA, Gupta MR, Dudas KC, Murphy TF, Apicella MA. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae Infection and Immunity. 55: 882-887. PMID 3549563 DOI: 10.1128/Iai.55.4.882-887.1987  0.337
1987 Murphy TF, Bernstein JM, Dryja DM, Campagnari AA, Apicella MA. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypable haemophilus influenzae: Pathogenic and epidemiological observations Journal of Infectious Diseases. 156: 723-731. PMID 2443581 DOI: 10.1093/Infdis/156.5.723  0.377
1986 Murphy TF, Bartos LC, Campagnari AA, Nelson MB, Apicella MA. Antigenic characterization of the P6 protein of nontypable Haemophilus influenzae Infection and Immunity. 54: 774-779. PMID 3491049 DOI: 10.1128/Iai.54.3.774-779.1986  0.359
1985 Apicella MA, Dudas KC, Campagnari A, Rice P, Mylotte JM, Murphy TF. Antigenic heterogeneity of lipid A of Haemophilus influenzae Infection and Immunity. 50: 9-14. PMID 3899941 DOI: 10.1128/Iai.50.1.9-14.1985  0.34
Show low-probability matches.